Menopause-related workload in general practice 1996-2005: A retrospective study in the UK

Family Practice

Volumn 27, Issue 5, 2010, Pages 499-506

  Iversen, Lisa ^a   Delaney, Elizabeth K ^a   Hannaford, Philip C ^a   Black, Corri ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Family practice; Menopause; Referral and consultation; Workload

Indexed keywords

AGENTS USED INTRAVAGINALLY; ANTIDEPRESSANT AGENT; CLONIDINE; DROSPIRENONE; DYDROGESTERONE; ESTRADIOL; ESTROGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; NORGESTREL; PROGESTERONE; TIBOLONE;

ADULT; ARTICLE; CONSULTATION; FEMALE; GENERAL PRACTICE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; MENOPAUSE; PATIENT REFERRAL; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; SUPPOSITORY; UNITED KINGDOM; VAGINA PESSARY; WORKLOAD;

ANTIDEPRESSIVE AGENTS; CLONIDINE; FEMALE; GENERAL PRACTICE; GREAT BRITAIN; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MENOPAUSE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; WORKLOAD;

EID: 77956916985     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmq038     Document Type: Article

References (23)

1. Porter M, Penney GC, Russell D, Russell E, Templeton A. A population based survey of women's experience of the menopause. BJOG 1996; 103: 1025-8.
2. Guthrie JR, Dennerstein L, Taffe JR, Donnelly V. Health careseeking for menopausal problems. Climacteric 2003; 6: 112-7.
3. McCormick A, Fleming D, Charlton J. Diseases of the genitourinary system. Morbidity Statistics from General Practice. Fourth National Study 1991-1992. A Study Carried Out by the Royal College of General Practitioners, the Office of Population Censuses and Surveys, and the Department of Health. London: HMSO, 1995: 53.
4. McCormick A, Rosenbaum M. CC293 menopausal symptoms (climacteric). Morbidity Statistics from General Practice. Third National Study 1981-1982. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health and Social Security. London: HMSO, 1986: 161.
5. Million Women Study Collaborators. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. BJOG 2002; 109: 1319-30.
6. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
7. Committee on Safety of Medicines & Medicines and Healthcare products Regulatory Agency. Review of the evidence on long-term safety of HRT. Curr Probl Pharmacovigilance 2004; 30: 4-7.
8. Watson J, Wise L, Green J. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 2007; 63: 843-9.
9. Mehta DK (ed.). Chapter 6.4.1.1 Oestrogens and Hrt, 6.4.1.2 Progestogens. British National Formulary BNF 52. London: BMJ Publishing Group & RPS Publishing, 2006, pp. 375-84.
10. Mehta DK. (ed.). Chapter 4.3 Antidepressant drugs. British National Formulary BNF 52. London: BMJ Publishing Group & RPS Publishing, 2006:, pp.198-208.
11. Writing Group for the British Menopause Society Council. Non-estrogen-based treatments for menopausal symptoms. Menopause Int 2008; 14: 88-90.
12. Scientific Advisory Committee Opinion Paper 6 Alternatives to HRT for the Management of Symptoms of the Menopause http://www.rcog.org.uk/womens-health/clinical-guidance/alternatives-hrt-management-symptoms-menopause (accessed on 5 March 2010).
13. Age Distribution and Currently Registered Patients in FF-GPRD and in the General Population http://gprd.com/academia/ (accessed on 15 October 2008).
14. Howie JGR. Diagnosis-the Achilles heel? J R Coll Gen Pract 1972; 22: 310-5.
15. Barlow DH, Brockie JA, Rees CMP. Oxford General Practitioners Menopause Study Group. Study of general practice consultations and menopausal problems. BMJ 1991; 302: 274-6.
16. Coulter A. What do patients and the public want from primary care? BMJ 2005; 331: 1199-201.
17. Williams RE, Kalilani L, DiBenedetti DB et al. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007; 58: 348-58.
18. Usher C, Teeling M, Bennett K, Feely J. Effect of clinical trial publicity on HRT prescribing in Ireland. Eur J Clin Pharmacol 2006; 62: 307-10.
19. Hersh AL, Stafanick ML, Stafford RS. National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA 2004; 291: 47-53.
20. de Jong-van den Berg LT, Faber A, van den Berg PB. HRT use in 2001 and 2004 in The Netherlands-a world of difference. Maturitas 2006; 54: 193-7.
21. Austin PC, Mamdani MM, Tu K. The impact on the Women's Health Initiative study on incident clonidine use in Ontario, Canada. Can J Clin Pharmacol 2004; 11: e191-4.
22. McIntyre RS, Konarski JZ, Grigoriadis S et al. Hormone replacement therapy and antidepressant prescriptions: a reciprocal relationship. CMAJ 2005; 172: 57-9.
23. Office for National Statistics Mid-2006 Population Estimates: Estimated Resident Population by Single Year of Age and Sex. http://www.statistics.gov.uk/downloads/ (accessed on 10 October 2008).